Acquisition Multiples: 1.9 times current revenue and roughly 15 times EBITDA. Tempus AI Inc (NASDAQ:TEM) reported a 33% revenue growth, reaching $180.9 million for Q3 2024. The company's data and ...
Dysfunctions of the tiny cell processes (primary cilia) of the pancreatic beta cells could be a cause of type 2 diabetes. Little is known about the structure and function of these cilia.